Literature DB >> 3164248

Nonrandom chromosomal abnormalities in malignant pleural mesothelioma.

M Tiainen1, L Tammilehto, K Mattson, S Knuutila.   

Abstract

Cytogenetic studies were performed on tumor cells from specimens of 30 consecutive patients with malignant pleural mesothelioma. Metaphases for chromosomal G-banding analyses were obtained from 27 of these patients. Clonal abnormalities were detected in 19 patients. Karyotype findings were complex and heterogeneous: aneuploidy, polyploidy, structural abnormalities, and several subclones were seen. The most frequent chromosomal abnormalities were polysomy or partial polysomy 7, monosomy or partial monosomy 22, and rearrangements involving breakpoints at 1p11-22.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3164248     DOI: 10.1016/0165-4608(88)90035-0

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  9 in total

Review 1.  [Pleural mesothelioma. Cytology and molecular diagnostics].

Authors:  T Vlajnic; S Savic; L Bubendorf
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

2.  Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines.

Authors:  Geula Klorin; Ester Rozenblum; Oleg Glebov; Robert L Walker; Yoonsoo Park; Paul S Meltzer; Ilan R Kirsch; Frederic J Kaye; Anna V Roschke
Journal:  Cancer Genet       Date:  2013-07-05

3.  High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.

Authors:  A B Bianchi; S I Mitsunaga; J Q Cheng; W M Klein; S C Jhanwar; B Seizinger; N Kley; A J Klein-Szanto; J R Testa
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

Review 4.  Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms.

Authors:  C Sreekantaiah; M Ladanyi; E Rodriguez; R S Chaganti
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

5.  Factors that impact susceptibility to fiber-induced health effects.

Authors:  Jennifer E Below; Nancy J Cox; Naomi K Fukagawa; Ari Hirvonen; Joseph R Testa
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

6.  Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma.

Authors:  M Tiainen; L Tammilehto; J Rautonen; T Tuomi; K Mattson; S Knuutila
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

7.  Phenotypes and karyotypes of human malignant mesothelioma cell lines.

Authors:  Vandana Relan; Leanne Morrison; Kylie Parsonson; Belinda E Clarke; Edwina E Duhig; Morgan N Windsor; Kevin S Matar; Rishendran Naidoo; Linda Passmore; Elizabeth McCaul; Deborah Courtney; Ian A Yang; Kwun M Fong; Rayleen V Bowman
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

Review 8.  Advances in the management of malignant mesothelioma.

Authors:  Mazen Y Khalil; Marissa Mapa; Hyung Ju C Shin; Dong M Shin
Journal:  Curr Oncol Rep       Date:  2003-07       Impact factor: 5.945

Review 9.  Cellular and molecular mechanisms of asbestos carcinogenicity: implications for biopersistence.

Authors:  J C Barrett
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.